Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery

Background— Percutaneous aortic valve implantation by an antegrade transvenous approach has been described but is problematic. Retrograde prosthetic aortic valve implantation via the femoral artery has potential advantages. Percutaneous prosthetic aortic valve implantation via the femoral arterial approach is described and the initial experience reported. Methods and Results— The valve prosthesis is constructed from a stainless steel stent with an attached trileaflet equine pericardial valve and a fabric cuff. After routine aortic balloon valvuloplasty, a 22F or 24F sheath is advanced from the femoral artery to the aorta. A steerable, deflectable catheter facilitates manipulation of the prosthesis around the aortic arch and through the stenotic valve. Rapid ventricular pacing is used to reduce cardiac output while the delivery balloon is inflated to deploy the prosthesis within the annulus. Percutaneous aortic prosthetic valve implantation was attempted in 18 patients (aged 81±6 years) in whom surgical risk was deemed excessive because of comorbidities. Iliac arterial injury, seen in the first 2 patients, did not recur after improvement in screening and access site management. Implantation was successful in 14 patients. After successful implantation, the aortic valve area increased from 0.6±0.2 to 1.6±0.4 cm2. There were no intraprocedural deaths. At follow-up of 75±55 days, 16 patients (89%) remained alive. Conclusions— This initial experience suggests that percutaneous transarterial aortic valve implantation is feasible in selected high-risk patients with satisfactory short-term outcomes.

[1]  W. Jamieson,et al.  Porcine bioprostheses in the elderly: clinical performance by age groups and valve positions. , 1995, The Annals of thoracic surgery.

[2]  T. Naqvi,et al.  Percutaneous stent‐mounted valve for treatment of aortic or pulmonary valve disease , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  F. Beyersdorf,et al.  Percutaneous aortic valve replacement: an experimental study. I. Studies on implantation , 2002 .

[4]  William Grossman,et al.  Cardiac Catheterization, Angiography, and Intervention , 1990 .

[5]  T. Feldman,et al.  Percutaneous balloon aortic valvuloplasty: Antegrade transseptal vs. conventional retrograde transarterial approach , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  T. Vassiliades,et al.  The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). , 2005, The Annals of thoracic surgery.

[7]  E. Antman,et al.  Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.

[8]  Younes Boudjemline,et al.  Steps Toward Percutaneous Aortic Valve Replacement , 2002, Circulation.

[9]  T. Schröder,et al.  Aortenklappenersatz bei 80- und über 80-jährigen , 2000, Zeitschrift für Gerontologie und Geriatrie.

[10]  T. Sundt,et al.  Quality of Life After Aortic Valve Replacement at the Age of >80 Years , 2000, Circulation.

[11]  J. Sochman,et al.  Percutaneous Transcatheter Aortic Disc Valve Prosthesis Implantation: A Feasibility Study , 2000, CardioVascular and Interventional Radiology.

[12]  P. Kolh,et al.  Cardiac surgery in octogenarians; peri-operative outcome and long-term results. , 2001, European heart journal.

[13]  J M Hasenkam,et al.  Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. , 1992, European heart journal.

[14]  T. Vassiliades,et al.  The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI) , 2005 .

[15]  M. Leon,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis First Human Case Description , 2002 .

[16]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.

[18]  O. Levang [Aortic valve surgery in the elderly]. , 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[19]  A. Bernstein,et al.  Aortic valve replacement in geriatric patients: determinants of in-hospital mortality. , 2001, The Annals of thoracic surgery.

[20]  P. Bonhoeffer,et al.  Percutaneous implantation of a valve in the descending aorta in lambs. , 2002, European heart journal.

[21]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[22]  W. O’Neill,et al.  Retrograde percutaneous aortic valve implantation for critical aortic stenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  Thomas A Vassiliades,et al.  The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI). , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  A. Berman,et al.  Predictors of event-free survival after balloon aortic valvuloplasty. , 1991, The New England journal of medicine.

[25]  N C Nanda,et al.  Evaluation of aortic insufficiency by Doppler color flow mapping. , 1987, Journal of the American College of Cardiology.

[26]  J. Anderson,et al.  Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. , 1986, Journal of the American College of Cardiology.

[27]  K S Pieper,et al.  Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. , 1995, Journal of the American College of Cardiology.

[28]  W. O’Neill Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. , 1991, Journal of the American College of Cardiology.

[29]  E. Nabel,et al.  Gene transfer into vascular cells. , 1991, Journal of the American College of Cardiology.

[30]  R A Nishimura,et al.  In-hospital mortality after balloon aortic valvuloplasty: frequency and associated factors. , 1991, Journal of the American College of Cardiology.